171 related articles for article (PubMed ID: 33117670)
1. Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review.
Chen X; Zhang P; Chen S; Zhu H; Wang K; Ye L; Wang J; Yu J; Mei S; Wang Z; Cheng X
Front Oncol; 2020; 10():1733. PubMed ID: 33117670
[No Abstract] [Full Text] [Related]
2. Prognostic implication of human papillomavirus types in cervical cancer patients: a systematic review and meta-analysis.
Xu Y; Qiu Y; Yuan S; Wang H
Infect Agent Cancer; 2020 Nov; 15(1):66. PubMed ID: 33292343
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.
Li P; Tan Y; Zhu LX; Zhou LN; Zeng P; Liu Q; Chen MB; Tian Y
Oncotarget; 2017 Sep; 8(39):66352-66359. PubMed ID: 29029517
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic role of human papillomavirus genotype in cervical cancer.
Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients.
Chen Q; Shi R; Liu Z; Shi Z; Gu K; Chen J; He Y; Li Y; Wu J; Ji S; Zhou J; Zhu J
J Cancer; 2020; 11(20):5911-5917. PubMed ID: 32922533
[No Abstract] [Full Text] [Related]
7. The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis.
Shi J; Wang L; Yao N; Sun L; Hu W; Li X; Yang Y; Wang Y; Zhu W; Li B
BMC Cancer; 2022 Jun; 22(1):658. PubMed ID: 35705893
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
9. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
[TBL] [Abstract][Full Text] [Related]
10. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
Yan S; Jiao X; Li K; Li W; Zou H
Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis.
Sun G; Dong X; Tang X; Qu H; Zhang H; Zhao E
Oncotarget; 2018 Jan; 9(8):8081-8088. PubMed ID: 29487716
[TBL] [Abstract][Full Text] [Related]
12. Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis.
Li Y; Qin Y
J Cancer Res Clin Oncol; 2020 Mar; 146(3):545-553. PubMed ID: 32036456
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
[TBL] [Abstract][Full Text] [Related]
15. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract][Full Text] [Related]
16. Impact of HR-HPV infection on oncological outcomes in early cervical cancer.
Su X; Liu P; Zhao H; Sun L; Wang W; Jin S; Wang H; Liu P; Chen C; Hao M
Front Oncol; 2023; 13():1264114. PubMed ID: 37700831
[TBL] [Abstract][Full Text] [Related]
17. Association between high body mass index and prognosis of patients with early-stage breast cancer: A systematic review and meta-analysis.
Li Z; Shen G; Shi M; Zheng Y; Guan Y; Xin Y; Wang M; Zhao F; Ren D; Zhao J
Cancer Pathog Ther; 2023 Jul; 1(3):205-215. PubMed ID: 38327841
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.
Pan D; Wei K; Ling Y; Su S; Zhu M; Chen G
Med Sci Monit; 2015 Mar; 21():882-9. PubMed ID: 25807305
[TBL] [Abstract][Full Text] [Related]
19. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
Zhu X; Wang Y; Zhu H; Lou W
Acta Otolaryngol; 2016 Dec; 136(12):1291-1298. PubMed ID: 27472193
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of immune checkpoint proteins in HPV-infected cervical cancer.
Zou W; Huang R; Li P; Liu X; Huang Q; Yue J; Liu C
J Infect Public Health; 2023 Apr; 16(4):542-550. PubMed ID: 36801634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
